Director, Preclinical Project Development and Strategic Lead

<div class="content-intro"><p style="line-height: 1.2;"><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three RD sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.</span></p> <p style="line-height: 1.2;"> </p> <p style="line-height: 1.2;"><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.</span></p> <p style="line-height: 1.2;"> </p></div><div class="col-xs-12 no-horiz-padding"><hr> <p><span style="font-size: 12pt; font-family: arial, helvetica, sans-serif;">Legend Biotech is seeking a <strong>Director, Preclinical Project Development and Strategic Lead </strong>as part of the <strong>Early-stage Drug Development </strong>team based in <strong>Somerset, NJ. </strong></span></p> <p><span style="font-size: 12pt; font-family: arial, helvetica, sans-serif;"><strong>R<span style="font-size: 12pt; font-family: arial, helvetica, sans-serif;">ole Overview</span></strong></span></p> <p><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">The Preclinical development and strategic lead is responsible for planning, executing and overseeing preclinical development projects of Legend. He or she will be responsible for managing cross-functional team, ensuring adherence to IND submission timelines, budgets and regulatory requirements and acting as central point of communication between stakeholders to advance Legend drug development efforts.</span> </p> <p><span style="font-size: 12pt; font-family: arial, helvetica, sans-serif;"><strong>Key Responsibilities</strong> </span></p> <ul> <li style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Preclinical IND enabling study oversight <ul> <li style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Work closely with program teams to develop preclinical IND strategies. Accountable for preclinical IND study delivery and quality</li> <li style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Developing and mange project plans, timelines, budgets and resources for preclinical IND programs</li> <li style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Coordinate and monitor preclinical studies, including in vitro and in vivo studies, ensuing alignment with program goals</li> <li style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Track project progress, identify risks and implement mitigation strategies to maintain timelines and deliverables</li> </ul> </li> <li style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Cross functional collaboration <ul> <li style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Serve as a liaison between internal departments (eg, research, toxicology, pharmacology, CMC, regulatory affairs) and eternal partners (e.g. CROs)</li> <li style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Facilitate communication and collaboration among multidisciplinary teams to achieve project milestones</li> <li style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Ensure preclinical studies comply with relevant regulatory ... (truncated, view full listing at source)